Contact Us

Safety and Toxicology Solutions to Bring Your Molecule to the Market

Europe-based CRO for integrated safety assessment, toxicology and efficacy testing.

Explore our services
Talk to an expert

Why Partner with Accelera as Your Preclinical CRO?

We are a Europe-based Contract Research Organization providing integrated safety assessment, toxicology, and efficacy testing for small molecules and biologics.

Our services are designed to de-risk development and support confident regulatory decisions worldwide.

We partner with biotech and pharma companies to deliver:

Expert guidance to identify and de-risk the fastest, safest path to IND with robust data for sound go/no-go decisions

GLP-compliant toxicology studies and safety assessments tailored to your molecule, including New Approach Methodologies (NAMs)

Actionable efficacy insights from oncology preclinical models and translational research

Built for Seamless Collaboration

Built on decades of experience working with drug development teams, our experts combine scientific rigor, operational reliability, and the highest standards of animal welfare – all under full GLP and AAALAC accreditation.

Regulator-Accepted GLP Toxicology Testing

Submit INDs without surprises or revisions

Senior-Level Partnership

Strategic guidance from toxicology studies design to regulatory submission

Predictable, On-Time Delivery of Preclinical Studies

Protect your timeline and budget

Global
client base
0 +
IND/CTA-enabling studies
GLP-compliant facilities
with ICH/OECD-aligned workflows
0
years of experience
All
therapeutic areas covered
> 0 %
on-time study delivery rate
0 +
in vivo oncology efficacy models

What Our Clients Say About Us

“Accelera has been a key partner in this journey. We highly value their scientific competence, reliability, and collaborative approach, which continue to contribute to the progress of our pipeline”

- CEO EU and US biotechnology company . Oncology

“Accelera has carried out all our GLP tolerance studies as well as other tox studies and we have always valued the dedication and expertise of the team in helping move our program forward.”

- CDO biotech company

“Accelera’s integrated approach provided us with actionable insights. Their scientific expertise and ability to design studies tailored to our specific need were instrumental in advancing the progress toward recieving approval to initiate our first in human clinical study.”

- CEO EU and US biotechnology company . Oncology

News & Events

Discover our latest announcements, conference participation, and key milestones in preclinical research.

Read More →

Company

Accelera traces its roots to over 60 years of pioneering pharmaceutical R&D at the Nerviano site in Italy, from groundbreaking oncology discoveries to modern CRO services.

Read More →

Resources

Browse our expert insights, publications, and downloadable resources to support your research decisions.

Read More →
Subscribe to our updates
Talk to an expert

Contact Us

How can we help you?

We are here to answer your questions.

Please send me more information about the following services:
Acceptance*
I have read the Privacy Notice and I allow processing my personal data

Subscribe to our updates